WP1 Staff exchange

Incoming visits

1. Professor Klaus Műller

Institution: F. Hoffmann-La Roche Ltd, Switzerland

Aim: Supervision and lecturing of series of seminars on Drug Discovery and Molecular Design.

Dates of exchange02.12.2013-17.12.2013.

Status: Implemented

 

2. Paul Cos

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: Presentation of Antwerp Drug Design Network, setting up collaboration, arranging of programme for joint symposium „Advanced anti-infective drug design” in 27-28th May 2014.

Dates of exchange04.12.2013-05.12.2013.

Status: Implemented.

 

3. Tim Raemaekers

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: Presentation of Antwerp Drug Design Network, setting up collaboration, arranging of programme for joint symposium „Advanced anti-infective drug design” in 27-28th May 2014.

Dates of exchange: 04.12.2013-05.12.2013.

Status: Implemented.

 

4. Professor Povl Krogsgaard-Larsen

Institution: University of Copenhagen, Denmark

Aim: Seminar “Amanita muscaria Toxins as Leads in Drug Design”, consultations on further collaboration.

Dates of exchange: 09.12.2013-11.12.2013.

Status: Implemented.

 

5. Professor Carsten Bolm

Institution: RWTH Aachen University, Germany.

Aim: Input in seminars

  • Scientific writing in chemistry
  • How much catalysts do we need?

Consultation to researchers on metal-catalyzed reactions, discussion on further joint collaboration.

Dates of exchange: 24.02.2014-26.02.2014.

Status: Implemented.

 

6. Professor Martin Billeter

Institution: Biophysics Group, Department of Chemistry, University of Gothenburg, Sweden

Aim: presentation in “800 MHz NMR Spectrometer Inauguration Symposium”, consultations to researchers, discussion on further joint collaboration.

Dates of exchange: 26.01.2014-27.01.2014.

Status: Implemented

7. Professor Guido Pintacuda

Institution: Centre de RMN à Très Hauts Champs, Ecole Normale Supérieure de Lyon, France

Aim : presentation in “800 MHz NMR Spectrometer Inauguration Symposium”, consultations to researchers, discussion on further joint collaboration.

Dates of exchange: 26.01.2014-28.01.2014.

Status : Implemented

 

8. Professor Klaus Műller

Institution: F. Hoffmann-La Roche Ltd, Switzerland

Aim presentation “Molecular Design in Drug Discovery” in the seminar „Advanced anti-infective drug design” and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”.

Dates of exchange: 26.05.2014 – 30.05.2014.

Status: Implemented

 

9. Prof. Koen Augustyns

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: presentation “ Medicinal chemistry & and drug design/evaluation” in the seminar “Advanced anti-infective drug discovery and design” and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”

Dates of exchange 26.05.2014 – 29.05.2014

Status: Implemented

 

10. Dr. Jurgen Joosens

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: Participation in the seminar “Advanced anti-infective drug discovery and design” and presentation “Capacity building & funding possibilities for academic drug discovery research, a Flemish approach” in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”.

Dates of exchange 26.05.2014 – 29.05.2014

Status: Implemented

 

11. Dr. Paul Cos

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: presentation “ Bacterial Biofilms” in the seminar “Advanced anti-infective drug discovery and design” and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

12. Dr. Louis Maes

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: presentation “Preclinical Drug Discovery” in the seminar “Advanced anti-infective drug discovery and design” and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design” .

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

13. Dr. Pieter Van der Veken

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: presentation “Medicinal chemistry & and drug design/evaluation II” in the seminar “Advanced anti-infective drug discovery and design” and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”.

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

14. Dr. Paul Bromann

Institution: University of Helsinki, Finland

Aim: participation in the seminar “Advanced anti-infective drug discovery and design” and presentation “Enhancing the value of university IP through public-private partnerships” in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

15. Prof Arto Urtti

Institution: University of Helsinki, Finland

Aim: presentation “Drug design & delivery” in the seminar “Advanced anti-infective drug discovery and design and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

16. Dr Paul Finn

Institution: InhibOx Ltd, Oxford Centre for Innovation, United Kingdom

Aim: presentation “Computer aided drug discovery” in the seminar “Advanced anti-infective drug discovery and design” and participation in the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

17. Dr. Marika Rupponen

Institution: University of Eastern Finland, Faculty of Pharmacy, Kuopio, Finland

Aim: participation in the seminar “Advanced anti-infective drug discovery and design” and the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”. Consultation of researchers about the methods for studies of delivery systems

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

18. Dr. Maija Lahtela-Kakkonen

Institution: University of Eastern Finland, Faculty of Pharmacy, Kuopio, Finland

Aim: participation in the seminar “Advanced anti-infective drug discovery and design” and the round table discussion “Possibilities for further collaboration in anti-infective drug discovery and design”. Consultation of researchers Theoretical aspects of oligonucleotide delivery systems

Dates of exchange 26.05.2014 – 28.05.2014

Status: Implemented

 

19. Dr. Detlef Walter Maria Hofmann

Institution: CRS4 - Centre for Advanced Studies, Research and Development in Sardinia, Italy

Aim: Consulting on FlexCryst software for structure solution from powder diffraction data

Dates of exchange 01.08.2014-31.08.2014

Status: Implemented

 

20. Dr. Liudmila N. Kuleshova

Institution: CRS4 - Centre for Advanced Studies, Research and Development in Sardinia, Italy

Aim: Consulting for result interpretation for predicted crystalline polymorphic forms

Dates of exchange 01.08.2014-31.08.2014

Status: Implemented

 

21. Prof. Antonello Mai

Institution: La Sapienza University, Rome, Italy Aim: Prof. Antonello Mai gave a seminar on the field of Epigenetic Enzyme Modulators for histone methylation and acetylation processes

Dates of exchange 30.11.2014 – 05.11.2014

Status: Implemented

 

22. Prof. Ari Koskinen

Institution: Aalto University, Helsinki

Aim: Prof. Koskinen gave a series of seminars on the field of asymmetric synthesis

Dates of exchange 11.05.2015 – 15.05.2015

Status: Implemented

 

23. Prof. Viatcheslav V. Jouikov

Institution: Molecular Chemistry and Photonics, University of Rennes, France

Aim: Discussion and coordination of synthetic efforts aiming redox active and spin-switching biologically active germanium derivatives. Prof. Viatcheslav V. Jouikov gave a seminar entitled as ‘’Electrochemistry of organic compounds of the group 14 elements and carbon functionalization. Putting together old concepts and new paradigms.’’

Dates of exchange 14.05.2014 – 13.06.2015

Status: Implemented

 

24. Dr. Maurice C.R. Franssen

Institution: Laboratory of Organic Chemistry, Wageningen University, The Netherlands

Aim: Associated Prof. Dr. Maurice C.R. Franssen gave seminars entitled as ‘’Biosynthetic strategies: how Nature makes molecules’’ and ‘’Chemo-enzymatic routes for the conversion of biobased compounds to bulk chemicals’’ and also consulted researchers on the field of application of enzymes and microbial cells as selective, environmentally friendly catalysts in organic synthesis.

Dates of exchange 31.05.2015 – 3.06.2015

Status: Implemented

 

25. Prof. Amedeo Caflisch

Institution: University of Zürich, Zürich, Switzerland

Aim: participation in the seminar “Molecular modeling in drug discovery” with presentation “Molecular dynamics in drug design”. Consultation of researchers on the field of Computational structural biology, development of in silico drug design methods.

Dates of exchange 04.06.2015 – 06.06.2015

Status: Implemented

 

26. Prof. Koen Augustyns

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: participation in the Drug Discovery Conference; oral presentation “Activity-based probes to image proteolytic activity in oncology” in the session “Anticancer and antimutagenic agents” of the Drug Discovery Conference.

Dates of exchange 28.08.2015 – 30.08.2015

Status: Implemented

27. Prof. Philippe Bertrand

Institution: University of Poitiers, Poitiers, France

Aim: participation in the Drug Discovery Conference; oral presentation “Histone deacetylase inhibitors-polymer conjugates for the epigenetic treatment of cancers” in the session “Epigenetics and histone deacylases” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 30.08.2015

Status: Implemented

 

28. Prof. Stefan Chlopicki

Jagellonian Centre for Experimental Therapeutics, Jagellonian University, Poland

Aim: participation in the Drug Discovery Conference; oral presentation “Towards experimental pharmacology of endothelium; focus on prostacylin (PGI2) and nitric oxide (NO)” in the session “Novel targets for the pharmacology of heart and vessels” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 29.08.2015

Status: Implemented

 

29. Prof. Michael McDonough

Institution: University of Oxford, UK

Aim: participation in the Drug Discovery Conference; oral presentation “Structural investigations on the inhibition of metallo-beta-lactamases” in the session “Protein x-ray crystallography in drug discovery” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 30.08.2015

Status: Implemented

 

30. Prof. Paul Finn

Institution: InhibOx, Oxford, UK

Aim: participation in the Drug Discovery Conference; participation in “Stake holder session: Industry and academia collaboration” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 29.08.2015

Status: Implemented

31. Prof. Dr. Erich Gnaiger

Institution: Innsbruck Medical University, Austria

Aim: participation in the Drug Discovery Conference; participation in “Stake holder session: Industry and academia collaboration” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 30.08.2015

Status: Implemented

 

32. Prof. Ad IJzerman

Institution: Leiden University, Leiden, Netherlands

Aim: participation in the Drug Discovery Conference; delivery of Plenary lecture “Kinetics in drug discovery. A case for G protein-coupled receptors”

Dates of exchange 27.08.2015 – 31.08.2015

Status: Implemented

 

33. Prof. Ari Koskinen

Institution: University of Helsinki, Finland

Aim: participation in the Drug Discovery Conference; oral presentation “Efficient stereochemical protection in the synthesis of pharmacologically active alkaloids” in the session “Natural compounds in drug discovery” of the Drug Discovery Conference.

Dates of exchange 28.08.2015 – 29.08.2015

Status: Implemented

 

34. Prof. Brian Lohse

Institution: University Copenhagen, Denmark

Aim: participation in the round table discussion with LIOS scientists; contribution in the Drug Discovery Conference; oral presentation “Discovery of small molecules and peptides, as epigenetic chemical compound tools, using DNA encoded libraries for HDM and HMT” in the session “Methylation and acetylation marks in Epigenetics” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 30.08.2015

Status: Implemented

35. Prof. Helgi Schiöth

Institution: Uppsala University, Sweden

Aim: participation in the Drug Discovery Conference; delivery of plenary lecture “Human drug targets: Major shifts in molecular class and indications”

Dates of exchange 27.08.2015 – 28.08.2015

Status: Implemented

 

36. Prof. Claudiu T.Supuran

Institution: University of Florence, Italy

Aim: participation in the Drug Discovery Conference; delivery of plenary lecture “Carbonic anhydrase IX: a membrane protein drug target for anticancer and antimetastatic agents”

Dates of exchange 27.08.2015 – 30.08.2015

Status: Implemented

 

37. Prof. Lidija Milkovic

Institution: Rudjer Boškovič Institute, Croatia

Aim: participation in the Drug Discovery Conference; oral presentation “4-Hydroxynonenal: Friend or foe of growth regulation” in the session “Regenerative medicine: Stem cells, pluripotent cells, differentiation, dedifferentiation, Gene and drug delivery” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 30.08.2015

Status: Implemented

 

38. Prof. Marjo Yliperttula

Institution: University of Helsinki, Finland

Aim: participation in the Drug Discovery Conference; oral presentation “Confirmed structure-based dynamics of PLL- and PEI-DNA nanoparticles” in the session “Regenerative medicine: Stem cells, pluripotent cells, differentiation, dedifferentiation, Gene and drug delivery” of the Drug Discovery Conference.

Dates of exchange 26.08.2015 – 29.08.2015

Status: Implemented

 

39. Dr. Eriks Kupce

Institution: Bruker Biospin Oxford, United Kingdom

Aim:

  • participation in the Drug Discovery Conference,
  • participation in the round table discussion with LIOS scientists on application of Hadamard NMR spectroscopy for small molecule structure analysis.
  • Implementation and testing of novel NMR experiments (Hadamard and Radon transform-based experiments, HCNMBC experiment) on LIOS NMR spectrometers.

Dates of exchange 25.08.2015 – 29.08.2015

Status: Implemented

 

40. Prof. Ago Rinken

Institution: Tartu University, Estonia

Aim: participation in the Drug Discovery Conference; oral presentation “Fluorescence probes for characterization GPCR complexes” in the session “G protein – coupled receptors: ligands for medicinal chemistry” of the Drug Discovery Conference.

Dates of exchange 27.08.2015 – 29.08.2015

Status: Implemented

 

41. Prof. Petri Pihko

Institution: University of Jyväskylä, Finland

Aim: participation in the Drug Discovery Conference; oral presentation “Noncovalent interactions in organocatalysis” in the session “Natural compounds in drug discovery” of the Drug Discovery Conference.

Dates of exchange 27.08.2015 – 29.08.2015

Status: Implemented

 

42. Prof. Jarl Wikberg

Institution: Uppsala University, BMC, Sweden

Aim: participation in the Drug Discovery Conference; oral presentation “Libiguins - new promising remedies for treatment of erectile dysfunction” in the session “Natural compounds in drug discovery” of the Drug Discovery Conference.

Dates of exchange 28.08.2015

Status: Implemented

 

43. Prof. Bente Frølund

Institution: University of Copenhagen, Denmark

Aim: Seminar “The quest for the elusive gamma-hydroxybutyric acid (GHB) receptor ”, participation in the round table discussion with LIOS scientists

Dates of exchange: 17.09.2015-19.09.2015.

Status: Implemented

 

44. Prof. Luidgi Vaccaro

Institution: Perugia University, Italy

Aim: Seminars “Green and sustainable chemistry a tutorial introductory overview”, “Developing new synthetic tools towards sustainability“and participation in the round table discussion with LIOS scientists

Dates of exchange: 08.11.2015-13.11.2015.

Status: Implemented

 

45. Dr Santa Veiksina

Institution: University of Tartu, Tartu, Estonia

Aim: Sigma-1 receptor studies by using fluorescence microscopy methods - visualization of sigma-1 receptors in live cells by TIRF (Total Internal Reflection Fluorescence) microscopy and FCS (Fluorescence Correlation Spectroscopy); influence of different sigma-1 receptor ligands (agonists and atagonists) and allosteric modulators on receptor intracellular localisation).

Dates of exchange: 02.11.2015.- 29.01.2016.

Status: Implemented

 

46. Dr Lauri Sikk

Institution: University of Tartu, Tartu, Estonia

Aim: presentation “Computational study of the copper-free Sonogashira cross-coupling reaction.” in the seminar “Application of Computational Methods in Chemistry” on 14th January 2016 and consultations to researchers, discussion on further joint collaboration.

Dates of exchange: 14.01.2016.- 15.01.2016.

Status: Implemented

 

47. Professor Peeter Burk

Institution: University of Tartu, Tartu, Estonia

Aim: presentation “Modeling lanthanoid chemistry“ in the seminar “Application of Computational Methods in Chemistry” on 14th January 2016 and consultations to researchers, discussion on further joint collaboration.

Dates of exchange: 14.01.2016.- 15.01.2016.

 

48. Dr Kaido Tämm

Institution: University of Tartu, Tartu, Estonia

Aim: presentation “QSAR in medicinal chemistry: predictive toxicology and drug design“in the seminar “Application of Computational Methods in Chemistry” on 14th January 2016 and consultations to researchers, discussion on further joint collaboration.

Dates of exchange: 14.01.2016.- 15.01.2016.

Status: Implemented

 

49. Dr Kaido Tämm

Institution: University of Tartu, Tartu, Estonia

Aim: presentation “QSAR in medicinal chemistry: predictive toxicology and drug design“in the seminar “Application of Computational Methods in Chemistry” on 14th January 2016 and consultations to researchers, discussion on further joint collaboration.

Dates of exchange: 14.01.2016.- 15.01.2016.

Status: Implemented

 

50. Daniel Baron

Institution: Palacký University in Olomouc, Czech Republic

Aim: Development and optimisation of capillary electrophoresis (CE) method for separation of partially hydrogenated N-containing heterocycles.

Dates of exchange: 01.03.2016.- 20.05.2016.

Status: Implemented

 

51. Monika Jürgenson

Institution: University of Tartu, Tartu, Estonia

Aim: Participation in studies of experimental behaviour models for applied research.

Dates of exchange: 11.04.2016.- 10.06.2016.

Status: Implemented

 

52. Prof. Ago Rinken

Institution: Tartu University, Estonia

Aim: Research related with understanding of regular mechanisms of sigma 1 receptors; Participation in design and discussions about scientific research planning connected with strategy of LIOS.

Dates of exchange 30.03.2016.- 01.06.2016.

Status: Implemented

 

53. Prof. Viatcheslav V. Jouikov

Institution: Molecular Chemistry and Photonics, University of Rennes, France

Aim: Synthesis of new hypercoordinated derivatives of silicon and germanium; phospha-sila(germa)tranes.

Dates of exchange 16.05.2014 – 16.06.2015

Status: Implemented

 

54. Prof. Alf Lamprecht

Institution: University of Besançon, France

Aim: presentation “Particulate drug delivery systems for anti-inflammatory therapy”

in International Conference on Organic and medicinal chemistry dedicated to Professor Gustavs Vanags 125 years anniversary;

- Consultation of researchers Theoretical aspects of oligonucleotide delivery systems.

Dates of exchange 16.05.2014 – 18.05.2015

Status: Implemented

 

55. Prof. Marijan Kočevar

Institution: University of Ljubljana, Ljubljana, Slovenia

Aim: presentation “Synthetic potential of some heterocyclic compounds”

in International Conference on Organic and medicinal chemistry dedicated to Professor Gustavs Vanags 125 years anniversary;

- consultations to researchers, discussion on further joint collaboration.

Dates of exchange 16.05.2014 – 19.05.2015

Status: Implemented

 

56. Prof., Dr. Povl Krogsgaard-Larsen

Institution: University of Copenhagen, Copenhagen, Denmark

Aim: -presentation “Heterocyclic isosterism: mushroom toxins, GABA and glutamate” in International Conference on Organic and medicinal chemistry dedicated to Professor Gustavs Vanags 125 years anniversary

  • consultations to researchers, discussion on further joint collaboration.

Dates of exchange 16.05.2015 – 19.05.2015

Status: Implemented

 

57. Daniel Baron

Institution: Palacký University in Olomouc, Czech Republic

Aim: Studies of various types of nanoparticles with capillary electrophoresis and Dynamic light scattering techniques.

Dates of exchange: 30.05.2016.- 29.06.2016.

Status: Implemented

 

58. Monika Jurgenson

Institution: University of Tartu, Tartu, Estonia

Aim: Studies of experimental model of neuropathic pain.

Dates of exchange: 14.06.2016.- 15.07.2016.

Status: Implemented

 

59. Regorius Leurs

Institution: VU University Amsterdam

Aim:

  • presentation of lecture “From fragments to property-based medchem optimization";
  • discussions on results of existing collaboration;
  • consideration of plans of further cooperation.

 

Dates of exchange: 20.04.2016.- 22.06.2016.

Status: Implemented

 

60. Dr. Jurgen Joosens

Institution: Antwerp Drug Design Network, University of Antwerp, Belgium.

Aim: participation in pre-BOS-2016 Roundtable entitled as ‘’Inflammation and cancer: chemistry-biology interface’’ with oral presentation “An intensive interplay between chemistry, biochemistry and biology to identify clinical applications for diphenyl phosphonate inhibitors” in the 4th discussion round: Road from anticancer to antiinflammation.

Dates of exchange 28.06.2016 – 2.07.2016

Status: Implemented

 

61. Dr. Marco Pieroni

Institution: University of Parma, Italy.

Aim: participation in pre-BOS-2016 Roundtable entitled as ‘’Inflammation and cancer: chemistry-biology interface’’ with oral presentation “Merging different drug discovery approaches to offer novel therapeutic options against mycobacterial infections” in the 5th discussion round: Anti-inflammations and anti-malarials .

Dates of exchange: 28.06.2016 – 2.07.2016

Status: Implemented

 

62. Professor Peter Nielsen

Institution: University of Copenhagen, Denmark

Aim: participation in International Conference Balticum Organicum Syntheticum; delivery of Plenary lecture “Towards Peptide Nucleic Acid (PNA) based Translation and Replication Systems”.

Dates of exchange: 02.07.2016-06. 07.2016

Status: Implemented.

 

63. Philippe Bertrand

Institution: University of Poitiers, Poitiers, France

Aim: participation in International Conference Balticum Organicum Syntheticum; and participation in the round table discussion on the field of epigenetics.

Dates of exchange 02.07.2016-06. 07.2016

Status: Implemented

 

64. Dr. Detlef Walter Maria Hofmann

Institution: CRS4 - Centre for Advanced Studies, Research and Development in Sardinia, Italy

Aim: to continue the systematic work in the field of molecular simulation for advanced drug design, which involves experimental and theoretical aspects of the design of pharmaceutical salts.

Dates of exchange 11.07.2014-12.08.2014

Status: Implemented

 

65. Professor Guido Pintacuda

Institution: Centre de RMN à Très Hauts Champs, Ecole Normale Supérieure de Lyon, France

Aim : Participation in the “Solid state NMR workshop” (programme attached) with presentations “Solid state NMR principles, applications in chemistry and biology” and “Successful writing of ERC grant application”, participation in the practicals on data processing and analysis. Consultation of LIOS researchers on the field of solid state NMR of proteins. Implementation of experimental methods developed in Lyon in the LIOS NMR laboratory. Round table discussions with researchers of LIOS on further practical collaboration.

Dates of exchange: 11.07.2016-15.07.2016.

Status : Implemented

 

66. Dr. Jan Stanek

Institution: Centre de RMN à Très Hauts Champs, Ecole Normale Supérieure de Lyon, France

Aim : Participation in the “Solid state NMR workshop” (programme attached) with presentation “Solid state NMR of proteins”, participation in the practicals at the spectrometer and practicals on data processing and analysis. Consultation of LIOS researchers on the field of solid state NMR of proteins. Implementation of experimental methods developed in Lyon in the LIOS NMR laboratory. Round table discussions with researchers of LIOS on further practical collaboration.

Dates of exchange: 11.07.2016-15.07.2016.

Status : Implemented

 

67. Dr Sachin Chaudhari

Institution: Centre de RMN à Très Hauts Champs, Ecole Normale Supérieure de Lyon, France

Aim : Participation in the “Solid state NMR workshop” (programme attached) with presentation “Solid state NMR of materials”, participation in the practicals at the spectrometer. Consultation of LIOS researchers on the field of solid state NMR of materials. Implementation of experimental methods developed in Lyon in the LIOS NMR laboratory.

Dates of exchange: 12.07.2016-14.07.2016.

Status : Implemented

 

68. Dr. Diane Cala

Institution: Centre de RMN à Très Hauts Champs, Ecole Normale Supérieure de Lyon, France

Aim : Participation in the “Solid state NMR workshop” (programme attached) with presentation “Protein sample preparation for solid state NMR”, participation in the practicals at the spectrometer and practicals on data processing and analysis. Consultation of LIOS researchers on the field of protein sample preparation for solid state NMR. Round table discussions with researchers of LIOS on further practical collaboration.

Dates of exchange: 11.07.2016-15.07.2016.

Status : Implemented

 

69. Dr. Andra Pica

Institution: Istituto di Biostrutture e Bioimmagini, Naples, Italy

Aim: Participation in the “Solid state NMR workshop” (programme attached), participation in the practicals on data processing and analysis. Consultation of LIOS researchers on the field of protein crystallization. Round table discussions with researchers of LIOS on further practical collaboration. Discussions with researchers of LIOS on preparation of a joint grant proposal.

Dates of exchange: 11.07.2016-15.07.2016.

Status : Implemented

 

70. Lidija Milkovic

Institution: Rudjer Boškovič Institute, Croatia

Aim: Discussion on the results of biological evaluation of the compounds synthesised at LIOS.

Dates of exchange 11.07.2016 – 15.07.2016

Status: Implemented

 

71. Tea Vukovic

Institution: Rudjer Boškovič Institute, Croatia

Aim: Discussion on the results of biological screening of a series of compounds, which have shown promising features in enhanced sensitivity of cancer cells in regards to normal cells.

Dates of exchange 11.07.2016 – 15.07.2016

Status: Implemented

 

72. Alena Tresova

Institution: International Clinical Research Centre of St.Anne's University Hospital in Brno (FNUSA-ICRS)

Aim:

  • Introduction of research facilities of LIOS;
  • Presentation of Research programmes of the The International Clinical Research Center of St. Anne's University Hospital Brno   (FNUSA-ICRC)” at LIOS;
  • Participation in the round table discussion with LIOS scientists for international cooperation within HORIZON 2020 programme.

Dates of exchange 18.08.2015 – 19.08.2015

Status: Implemented

 

73. Jan Petr

Institution: Palacký University Olomouc, Czech Republic

http://ach.upol.cz/en/laborator-elektromigracnich-metod.php

Aim: Discussion on the results of implementation of nanoparticles in capillary electrophoresis and future collaboration between laboratory of membrane active compounds of LIOS and Department of Analytical Chemistry Palacký University of Olomouc

Dates of exchange 29.08.2015 – 31.08.2015

Status: Implemented

 

Updated 31.08.2016